Berkshire Hathaway Roughly Tripled $10,000 in a Decade. Did It Beat the Market?

Berkshire’s B shares rose from $148.64 (Aug. 25, 2016) to $504.32 (Aug. 25, 2026), turning a $10,000 stake into about $33,900, versus ~$41,300 for the S&P 500 (SPY) with dividends reinvested—about $7,400 ahead. Operating earnings grew from $17.6B in 2016 to $44.5B in 2025, with 2Q operating earnings up 16% YoY and $4.5B of buybacks in the quarter (plus $235M in 1Q). The article flags valuation risk: shares trade ~21x annualized 2Q operating earnings, implying the stock is no longer the earlier-decade “bargain,” even though it has compounded through business growth rather than multiple expansion.

Analysis

Berkshire is still behaving like a high-quality compounder, but not a market leader: the stock is mostly a function of how fast the underlying businesses can expand per share, not a rerating story. That matters because the market’s current premium is concentrated in long-duration growth, so BRK.B is more likely to keep lagging in a risk-on, AI-driven tape unless breadth broadens or rates fall enough to compress the index’s growth multiple.

The more important takeaway is that Berkshire’s buyback engine and float create a built-in defensive bid, which lowers left-tail risk versus typical conglomerates. That said, at roughly low-20s times operating earnings, the margin of safety is thinner than the “cheap conglomerate” narrative suggests; the stock is now more of a quality bond proxy than a deep-value trade. If operating earnings merely hold flat, per-share growth can still continue, but upside is likely capped unless capital allocation improves or the market sells off.

The contrarian read is that investors may be overusing reported earnings multiples and underestimating the embedded optionality of Berkshire’s cash pile and float in a drawdown. The flip side is that the market may also be right that the best years of easy relative outperformance are behind it: without a major acquisition, a spike in insurance profitability, or a broad equity correction, BRK.B probably remains a steady compounding hold rather than a source of alpha.

Key Decisions for Investors

• Underweight BRK.B vs SPY/QQQ over the next 1-3 months; the setup favors capital-preservation over outperformance unless mega-cap tech multiple compression begins.
• Pair trade: long BRK.B / short QQQ on any AI-led extension higher; target is relative defense if market breadth weakens, with a stop if QQQ keeps outperforming and NVDA continues to raise forward spend expectations.
• For long-only portfolios, buy BRK.B only on a pullback toward a more compelling operating-earnings multiple or if shares trade 8-10% below the recent high; at current levels the risk/reward is more balanced than attractive.
• Watch Berkshire's next operating-earnings print and buyback pace as the real catalyst; if repurchases slow materially or operating earnings flatten for 2+ quarters, the defensive premium should compress.
• Use BRK.B as a volatility hedge, not an alpha engine: hold it versus cash or defensives, but avoid expecting multiple expansion absent a market correction or a major capital deployment event.